Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 06-Oct-2021
No. of pages: 106
Inquire Before Buying

Global Meningococcal Conjugate Scope and Market Size

Meningococcal Conjugate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Conjugate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Menactra

- Menveo

- NeisVac-C

- Nimenrix

- Others

Segment by Application

- Children

- Preteens or Teens

- Adults

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Sanofi Pasteur

- Pfizer

- Glaxo Smith Kline

- Hualan Biological Engineering

- JN International Medical Corporation

- Baxter International

- Merck

- Serum Institute of India

- Biomed

- Novartis

Global and United States Meningococcal Conjugate Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by Application
1.3.1 Global Meningococcal Conjugate Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2016-2027)
2.2 Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2016-2021)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027)
2.3 Meningococcal Conjugate Industry Dynamic
2.3.1 Meningococcal Conjugate Market Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2016-2021)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2016-2021)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2020
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2016-2021)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027)
5 Meningococcal Conjugate Breakdown Data by Application
5.1 Global Meningococcal Conjugate Historic Market Size by Application (2016-2021)
5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2016-2027)
6.2 North America Meningococcal Conjugate Market Size by Type
6.2.1 North America Meningococcal Conjugate Market Size by Type (2016-2021)
6.2.2 North America Meningococcal Conjugate Market Size by Type (2022-2027)
6.2.3 North America Meningococcal Conjugate Market Size by Type (2016-2027)
6.3 North America Meningococcal Conjugate Market Size by Application
6.3.1 North America Meningococcal Conjugate Market Size by Application (2016-2021)
6.3.2 North America Meningococcal Conjugate Market Size by Application (2022-2027)
6.3.3 North America Meningococcal Conjugate Market Size by Application (2016-2027)
6.4 North America Meningococcal Conjugate Market Size by Country
6.4.1 North America Meningococcal Conjugate Market Size by Country (2016-2021)
6.4.2 North America Meningococcal Conjugate Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2016-2027)
7.2 Europe Meningococcal Conjugate Market Size by Type
7.2.1 Europe Meningococcal Conjugate Market Size by Type (2016-2021)
7.2.2 Europe Meningococcal Conjugate Market Size by Type (2022-2027)
7.2.3 Europe Meningococcal Conjugate Market Size by Type (2016-2027)
7.3 Europe Meningococcal Conjugate Market Size by Application
7.3.1 Europe Meningococcal Conjugate Market Size by Application (2016-2021)
7.3.2 Europe Meningococcal Conjugate Market Size by Application (2022-2027)
7.3.3 Europe Meningococcal Conjugate Market Size by Application (2016-2027)
7.4 Europe Meningococcal Conjugate Market Size by Country
7.4.1 Europe Meningococcal Conjugate Market Size by Country (2016-2021)
7.4.2 Europe Meningococcal Conjugate Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2016-2027)
8.2 Asia-Pacific Meningococcal Conjugate Market Size by Type
8.2.1 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2027)
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Application
8.3.1 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2027)
8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region
8.4.1 Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2016-2027)
9.2 Latin America Meningococcal Conjugate Market Size by Type
9.2.1 Latin America Meningococcal Conjugate Market Size by Type (2016-2021)
9.2.2 Latin America Meningococcal Conjugate Market Size by Type (2022-2027)
9.2.3 Latin America Meningococcal Conjugate Market Size by Type (2016-2027)
9.3 Latin America Meningococcal Conjugate Market Size by Application
9.3.1 Latin America Meningococcal Conjugate Market Size by Application (2016-2021)
9.3.2 Latin America Meningococcal Conjugate Market Size by Application (2022-2027)
9.3.3 Latin America Meningococcal Conjugate Market Size by Application (2016-2027)
9.4 Latin America Meningococcal Conjugate Market Size by Country
9.4.1 Latin America Meningococcal Conjugate Market Size by Country (2016-2021)
9.4.2 Latin America Meningococcal Conjugate Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2016-2027)
10.2 Middle East & Africa Meningococcal Conjugate Market Size by Type
10.2.1 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2027)
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Application
10.3.1 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2027)
10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country
10.4.1 Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Details
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Details
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Details
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2016-2021)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Details
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2016-2021)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2016-2021)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Meningococcal Conjugate Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Meningococcal Conjugate Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Regions (2016-2021)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2016-2021)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Meningococcal Conjugate Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by Application (2016-2021)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Meningococcal Conjugate Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Meningococcal Conjugate Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Meningococcal Conjugate Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Meningococcal Conjugate Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million)
Table 64. Sanofi Pasteur Company Details
Table 65. Sanofi Pasteur Business Overview
Table 66. Sanofi Pasteur Meningococcal Conjugate Product
Table 67. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 68. Sanofi Pasteur Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Meningococcal Conjugate Product
Table 72. Pfizer Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Glaxo Smith Kline Company Details
Table 75. Glaxo Smith Kline Business Overview
Table 76. Glaxo Smith Kline Meningococcal Conjugate Product
Table 77. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 78. Glaxo Smith Kline Recent Development
Table 79. Hualan Biological Engineering Company Details
Table 80. Hualan Biological Engineering Business Overview
Table 81. Hualan Biological Engineering Meningococcal Conjugate Product
Table 82. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 83. Hualan Biological Engineering Recent Development
Table 84. JN International Medical Corporation Company Details
Table 85. JN International Medical Corporation Business Overview
Table 86. JN International Medical Corporation Meningococcal Conjugate Product
Table 87. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 88. JN International Medical Corporation Recent Development
Table 89. Baxter International Company Details
Table 90. Baxter International Business Overview
Table 91. Baxter International Meningococcal Conjugate Product
Table 92. Baxter International Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 93. Baxter International Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Meningococcal Conjugate Product
Table 97. Merck Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Serum Institute of India Company Details
Table 100. Serum Institute of India Business Overview
Table 101. Serum Institute of India Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 102. Serum Institute of India Recent Development
Table 103. Biomed Company Details
Table 104. Biomed Business Overview
Table 105. Biomed Meningococcal Conjugate Product
Table 106. Biomed Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 107. Biomed Recent Development
Table 108. Novartis Company Details
Table 109. Novartis Business Overview
Table 110. Novartis Meningococcal Conjugate Product
Table 111. Novartis Revenue in Meningococcal Conjugate Business (2016-2021) & (US$ Million)
Table 112. Novartis Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Share by Type: 2020 VS 2027
Figure 2. Menactra Features
Figure 3. Menveo Features
Figure 4. NeisVac-C Features
Figure 5. Nimenrix Features
Figure 6. Others Features
Figure 7. Global Meningococcal Conjugate Market Share by Application: 2020 VS 2027
Figure 8. Children Case Studies
Figure 9. Preteens or Teens Case Studies
Figure 10. Adults Case Studies
Figure 11. Meningococcal Conjugate Report Years Considered
Figure 12. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Meningococcal Conjugate Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Meningococcal Conjugate Market Share by Regions: 2020 VS 2027
Figure 15. Global Meningococcal Conjugate Market Share by Regions (2022-2027)
Figure 16. Global Meningococcal Conjugate Market Share by Players in 2020
Figure 17. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Conjugate as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2020
Figure 19. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021)
Figure 20. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027)
Figure 21. North America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 23. North America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 24. North America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 25. United States Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 29. Europe Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 30. Europe Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 31. Germany Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Meningococcal Conjugate Market Share by Region (2016-2027)
Figure 41. China Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 49. Latin America Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 50. Latin America Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 51. Mexico Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Meningococcal Conjugate Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Meningococcal Conjugate Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Meningococcal Conjugate Market Share by Country (2016-2027)
Figure 57. Turkey Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Meningococcal Conjugate Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 62. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 63. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 64. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 65. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 67. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 68. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs